HCRN-BRE93-1

A Phase II Study of Oral Etoposide and Ifosfamide in the Treatment of Patients with Stage IV Breast Cancer

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial HCRN-BRE93-1 being conducted in.
No data was found